刘贻声 1张广湘 1黄炜瑜 1梁锦源 1卢忠 2孔繁圃3
作者信息
- 1. 威科检测集团有限公司
- 2. 中国药品监督管理研究会医疗器械监管研究专业委员会
- 3. 清华大学医学院
- 折叠
摘要
Abstract
Large animal studies for medical devices is a pivotal step in the transition from basic research to clinical application.Their scientific design and standardized execution directly influence the effectiveness of registration submissions.Based on domestic and international regulatory requirements,including the Guidelines for Registration Review of Animal Studies on Medical Devices,this paper systematically constructs three core dimensions for evaluating large animal studies:safety assessment,effectiveness validation,and performance analysis.Firstly,the paper briefly elaborates on the role of large animal studies within regulatory policies,industrial development,and scientific evaluation systems,clarifying their necessity as a"gatekeeper"in preclinical evaluation.Secondly,focusing on the core element of experimental design,it provides a detailed analysis of key control points,including study subject assessment,scientific selection of animal models,sample size estimation,control group settings,and the construction of evaluation indicators,while emphasizing standardized management of raw records.Finally,from the perspectives of GLP compliance,data integrity assurance,and whole-process quality control,the paper explores implementation pathways to ensure the scientific rigor and regulatory acceptability of experimental data.This study aims to provide a systematic reference for protocol design for medical device R&D enterprises and research institutions,thereby enhancing the reliability and translation efficiency of preclinical evaluations.关键词
医疗器械/大动物试验/方案设计/关键控制点/数据可靠性/质量体系规范Key words
medical devices/large animal experiments/protocol design/key control points/data reliability/quality system specification分类
医药卫生
